Evogene Ltd. (EVGN)
0.5076
-0.03
(-5.63%)
USD |
NASDAQ |
Sep 08, 16:00
0.5002
-0.01
(-1.46%)
After-Hours: 20:00
Evogene Shareholders Equity (Quarterly) : -3.29M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.29M |
| March 31, 2026 | -2.545M |
| December 31, 2025 | -0.082M |
| September 30, 2025 | 1.142M |
| June 30, 2025 | -3.55M |
| March 31, 2025 | -3.645M |
| December 31, 2024 | -1.451M |
| September 30, 2024 | -4.343M |
| June 30, 2024 | 3.067M |
| March 31, 2024 | 8.289M |
| December 31, 2023 | 12.05M |
| September 30, 2023 | 18.51M |
| June 30, 2023 | 14.29M |
| March 31, 2023 | 22.09M |
| December 31, 2022 | 27.93M |
| September 30, 2022 | 30.58M |
| June 30, 2022 | 36.95M |
| March 31, 2022 | 45.53M |
| December 31, 2021 | 53.65M |
| September 30, 2021 | 60.69M |
| June 30, 2021 | 66.40M |
| March 31, 2021 | 71.54M |
| December 31, 2020 | 46.04M |
| September 30, 2020 | 44.93M |
| June 30, 2020 | 39.76M |
| Date | Value |
|---|---|
| March 31, 2020 | 43.98M |
| December 31, 2019 | 50.14M |
| September 30, 2019 | 56.09M |
| June 30, 2019 | 42.59M |
| March 31, 2019 | 46.53M |
| December 31, 2018 | 50.05M |
| September 30, 2018 | 55.50M |
| June 30, 2018 | 59.95M |
| March 31, 2018 | 64.35M |
| December 31, 2017 | 69.38M |
| September 30, 2017 | 75.00M |
| June 30, 2017 | 79.34M |
| March 31, 2017 | 83.31M |
| December 31, 2016 | 87.29M |
| September 30, 2016 | 93.28M |
| June 30, 2016 | 97.69M |
| March 31, 2016 | 101.34M |
| December 31, 2015 | 103.75M |
| September 30, 2015 | 108.09M |
| June 30, 2015 | 110.35M |
| March 31, 2015 | 113.69M |
| December 31, 2014 | 116.08M |
| September 30, 2014 | 120.29M |
| June 30, 2014 | 121.83M |
| March 31, 2014 | 123.93M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd. | 88.73M |
| Pluri, Inc. | -18.60M |
| Scinai Immunotherapeutics Ltd. | 11.73M |
| CollPlant Biotechnologies Ltd. | 4.886M |
| Regentis Biomaterials Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.44M |
| Total Liabilities (Quarterly) | 4.542M |
| Debt to Equity Ratio | -0.6386 |
| Current Ratio | 3.566 |
| Net Debt Paydown Yield | 1.65% |